The University of Illinois researchers invite you to participate in a voluntary study of physical activity and social cognitive determinants in people with Multiple Sclerosis.
July 15, 2014
PRODEDURE OF STUDY:
Before you wear an accelerometer, you will complete 9 questionnaires first and then wear an accelerometer for 7 days. The questionnaires will take approximately 1.5 hours to complete.
The accelerometer is a small mechanical device on your belt that measures movement. When you wear the accelerometer, you will fill out the log of wearing the accelerometer each day for 7 days. After you wear the accelerometer for 7 days, you will complete the remaining 4 questionnaires. The remaining questionnaires will take approximately 30 minutes to complete. You will return the completed questionnaires, the accelerometer and the signed consent form in the self-addressed, stamped envelope that came in the mail. You will do this now and 2 more times six and twelve months from now. We will contact you prior to and during the course of the study to verify responses or answer questions on the use of the accelerometer.
You will receive $10 each time you complete the assessments (initial, 6 months, and 12 months) for a total of $30. You will be paid a total of $30 for completing the baseline and 2 follow-up assessments. This amount will be prorated such that you will receive $10 for completing each of the three assessments. We have attached you a $10 gift card that expresses our sincere gratitude to your kind and great help with our MS research.
BENEFITS OF PARTICIPATION:
· Contribute to ongoing research in Multiple Sclerosis.
· Learn about your physical activity habits.
· Receive up to $30 compensation.
· Diagnosis of Relapsing-Remitting MS
· Ambulatory with or without a cane
· Age between 18-64 years
For more information, contact Dr. Chung-Yi Chiu by telephone (844) 800-9972 or e-mail at email@example.com.
About Multiple Sclerosis
Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.